FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases

BioPharma

Related Keywords

New York ,United States ,Lou Gehrig ,Joe Biden ,Billy Dunn ,Tanabe Pharma Radicava ,Critical Path Institute ,Amylyx Pharmaceuticals ,Us Department Of Health ,Human Services ,National Institutes Of Health ,Drug Administration ,Dive Brief ,National Institutes ,Critical Path ,Rare Neurodegenerative Diseases ,President Joe Biden ,New York Yankees ,Tanabe Pharma ,Brainstorm Cell Therapeutics ,